Aim at 95% adherence to PIs.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D010349:Patient Compliance
D017320:HIV Protease Inhibitors